NeoGenomics Inc (NEO)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 902,339 | 941,537 | 998,023 | 1,108,280 | 694,294 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $902,339K
= 0.00
The debt-to-equity ratio for NeoGenomics Inc has remained consistently at 0.00 for the years 2020 through 2024. This indicates that the company has not taken on any debt to finance its operations and has been relying solely on equity to support its growth and activities. A debt-to-equity ratio of 0.00 is typically viewed positively by investors and lenders as it suggests a lower financial risk and a stronger financial position, with the company having no financial leverage. However, it's important to note that a very low debt-to-equity ratio can also indicate limited access to capital for potential growth opportunities.